GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Avid Bioservices Inc.
Avid Bioservices is a contract manufacturing organization (CDMO) specializing in the production of biologics for other pharmaceutical companies. Its stock price is dependent on its production capacity utilization, which is determined by the overall health of the biotech industry and the extent of its R&D outsourcing.
Share prices of companies in the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that provides biopharmaceutical development and manufacturing services to other companies. We've categorized it as a "Pharma Tester." The chart below shows how the pharmaceutical industry's outsourcing sector is faring.
Broad Market Index - GURU.Markets
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other companies produce biologics. Its key role in the pharmaceutical industry makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Avid compares to it.
Change in the price of a company, segment, and market as a whole per day
CDMO - Daily change in the company's share price Avid Bioservices Inc.
The daily fluctuations of Avid Bioservices, Inc., a contract manufacturer for the pharmaceutical industry, reflect the volatility of the healthcare sector. This metric is a measure of the sensitivity of its production capacity to demand.
Daily change in the price of a set of shares in a market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that provides biologics development and manufacturing services to other pharmaceutical companies. Its business depends on the health of the entire biotech industry. The chart below shows the volatility in this sector, helping to assess the dynamics of CDMOs.
Daily change in the price of a broad market stock, index - GURU.Markets
Avid Bioservices is a contract manufacturer that helps other biotech companies produce their drugs. Its business serves as a barometer for the health of the entire biotech industry. Its stock price reflects investment in the sector and influences the overall market environment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Avid Bioservices Inc.
For Avid Bioservices, Inc., year-over-year performance is a reflection of its role as a contract manufacturer (CDMO) for the biopharmaceutical industry. Its market capitalization growth over the past 12 months reflects the demand for its biologics manufacturing services. Each new contract with a major pharmaceutical company is a testament to its manufacturing capacity.
Annual dynamics of market capitalization of the market segment - Pharma tests
Avid Bioservices, Inc. is a contract manufacturer of biologics. Its business benefits from the growing number of biotech companies seeking outsourced manufacturing. The chart below shows how its expertise in this complex field and the growth of the entire biotech industry contribute to its outperformance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Avid Bioservices, a contract manufacturer for the pharmaceutical industry, is an "infrastructure" bet on biotech. Its performance relative to the market is a barometer of the health of the entire industry. The growth of the biotech sector is leading to increased orders and allowing the company to outpace the market without taking on the risks of clinical trials.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) for biologics. Its business depends on R&D spending in the pharmaceutical industry. Monthly fluctuations in its value reflect news of major manufacturing contracts.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that produces biologics for other pharmaceutical companies. Demand for CDMO services is growing alongside the biopharmaceutical industry. The chart below shows how investors assessed the prospects of biotech "factories," which are a crucial part of the industry.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Avid Bioservices is a contract manufacturer (CDMO) that helps other pharmaceutical companies produce biologics. Its business is growing alongside the biotech industry. Its stock price is a barometer of the health and investment activity of the entire pharmaceutical industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other companies produce biopharmaceuticals. Its weekly stock price is driven by demand for outsourcing in the pharmaceutical industry and news about its manufacturing capacity utilization.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Avid Bioservices is a contract manufacturer of biologics for other pharmaceutical companies. Its business depends on outsourcing trends in the pharmaceutical industry and the success of its clients. The chart below helps us understand whether Avid's performance reflects general industry trends or whether its order book and manufacturing capacity create a unique profile.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Avid Bioservices is a contract manufacturer (CDMO) for pharmaceutical companies. Its business is stable, as pharmaceutical companies always need to produce drugs. The chart will show whether this stability results in lower volatility for the company's shares than the overall market.
Market capitalization of the company, segment and market as a whole
CDMO - Market capitalization of the company Avid Bioservices Inc.
The market capitalization of Avid Bioservices, a contract manufacturer of biologics (CDMO), reflects the growth of the entire biotech industry. Its robust growth chart demonstrates how investors value its role as a "factory" for the many pharmaceutical companies that outsource their drug production to it.
CDMO - Share of the company's market capitalization Avid Bioservices Inc. within the market segment - Pharma tests
Avid Bioservices is a contract manufacturer in the biopharmaceutical industry. Its share of the sector's market capitalization reflects its production capacity and client portfolio. The chart shows how its share changes amid growing demand for biologics and competition among outsourcing companies.
Market capitalization of the market segment - Pharma tests
The chart below shows the total value of the contract drug manufacturing (CDMO) sector. Avid Bioservices is one of its notable players, specializing in the production of antibody-based biologics. The growth of this market, which you can see, reflects the increasing number of biotech companies opting to outsource complex manufacturing, and Avid is a key contractor.
Market capitalization of all companies included in a broad market index - GURU.Markets
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other pharmaceutical companies produce biologics. Its market capitalization reflects its role in this supply chain. The chart below shows the importance of outsourcing in biotech.
Book value capitalization of the company, segment and market as a whole
CDMO - Book value capitalization of the company Avid Bioservices Inc.
Avid Bioservices' book value is derived from its state-of-the-art biopharmaceutical manufacturing facilities, which it provides to other companies for contract drug manufacturing (CDMO). The chart shows how this services provider is investing in its plants and equipment to meet growing demand from the biotech industry.
CDMO - Share of the company's book capitalization Avid Bioservices Inc. within the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) for biopharmaceuticals. The chart directly shows its share of physical assets. Its business consists of owning and operating modern, certified manufacturing facilities that serve as the material base for drug production for other pharmaceutical companies.
Market segment balance sheet capitalization - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biologics for other pharmaceutical companies. Unlike R&D startups, their business is highly capital-intensive and requires expensive bioreactors and sterile production lines, as reflected in the graph.
Book value of all companies included in the broad market index - GURU.Markets
Avid Bioservices' assets include a state-of-the-art contract manufacturing facility for complex biological drugs (antibodies) for other pharmaceutical companies. The chart below shows the growth of this high-tech manufacturing facility.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Avid Bioservices Inc.
The Avid Bioservices chart is a visualization of its manufacturing capacity valuation. The company is a contract manufacturer of biopharmaceuticals. Its balance sheet is comprised of plants and equipment. The chart shows how the market values โโthese assets: as mere hardware or as a key element in the production chain of expensive drugs, adding a premium for experience and contracts.
Market to book capitalization ratio in a market segment - Pharma tests
Avid Bioservices is a contract manufacturer of biopharmaceuticals for other companies. Its primary assets are its state-of-the-art manufacturing facilities. The chart shows how the market values โโthese expensive assets and the growing demand for outsourcing services in the pharmaceutical industry, which directly impacts the utilization of its plants.
Market to book capitalization ratio for the market as a whole
Avid Bioservices is a contract manufacturer for the pharmaceutical industry, which requires significant capital investment in equipment. This metric helps compare market valuation with investment in production capacity. A higher valuation than the market average indicates high profitability, technological advantages, and long-term contracts.
Debts of the company, segment and market as a whole
CDMO - Company debts Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other companies produce biologics. This chart shows how the company is investing in expanding its manufacturing capacity. Debt is being used to build and equip new lines to meet growing demand from the biotech industry.
Market segment debts - Pharma tests
Avid Bioservices is a contract manufacturer (CDMO) for the biopharmaceutical industry, helping other companies produce complex biologics. Expanding production capacity requires significant capital investment. This chart shows how the company is funding its growth to meet demand from the pharmaceutical industry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Avid Bioservices Inc.
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. This chart shows its debt load. A manufacturing company uses debt to expand capacity. Investors should evaluate whether this growth is supported by long-term contracts with reliable customers.
Market segment debt to market segment book capitalization - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that provides biopharmaceutical development and manufacturing services. This chart shows the debt burden in the pharmaceutical services sector. It helps understand how CDMOs are financing the expansion of their manufacturing capacity to meet growing demand from biotech companies.
Debt to book value of all companies in the market
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Expanding production capacity requires significant capital investment. This total market debt chart helps assess how the company is financing its growth and how its debt load aligns with overall industry trends.
P/E of the company, segment and market as a whole
P/E - Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other pharmaceutical and biotech companies produce complex antibody-based biologics. This chart shows how investors view outsourcing in the pharmaceutical industry, which is seeing growing demand.
P/E of the market segment - Pharma tests
Avid Bioservices is a contract development and manufacturing organization (CDMO). It helps other pharmaceutical and biotech companies produce complex biologics for clinical trials and commercialization. This chart shows the average valuation for the pharmaceutical testing sector, reflecting how investors value outsourcing in biopharma.
P/E of the market as a whole
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other pharmaceutical companies produce biologics. Its business depends on the volume of R&D in the pharmaceutical industry. This general sentiment graph influences biotech funding, but for Avid, the long-term trend toward outsourcing manufacturing in the pharmaceutical industry is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Avid Bioservices Inc.
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures antibody-based therapeutics for other companies. This chart shows future revenue expectations, which depend on the company's ability to attract new projects from pharmaceutical companies and its manufacturing capacity utilization.
Future (projected) P/E of the market segment - Pharma tests
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other biopharmaceutical companies produce monoclonal antibody drugs. This chart shows general expectations for the healthcare sector. The CDMO's position relative to the average reflects market perceptions of the quality of their manufacturing facilities and the demand for their services.
Future (projected) P/E of the market as a whole
Avid Bioservices is a contract development and manufacturing organization (CDMO) that provides services for the creation of biopharmaceuticals from mammalian cells. The company helps other pharmaceutical companies manufacture drugs. This chart of overall market expectations provides a backdrop for assessing the biotech sector, whose growth directly fuels demand for Avid's services.
Profit of the company, segment and market as a whole
Company profit Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps biotech companies produce complex biologics for clinical trials and commercialization. Its revenue curve reflects the demand for its manufacturing capacity, which is growing alongside the development of the biopharmaceutical industry.
Profit of companies in the market segment - Pharma tests
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps biopharmaceutical companies manufacture complex biologics. This chart shows the overall profitability of the pharmaceutical testing sector. It reflects the volume of R&D investments by pharmaceutical companies, which directly drives business for all contract manufacturers.
Overall market profit
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Demand for its services depends on the level of investment in biotechnology. When overall market profits rise, as in this chart, pharmaceutical companies invest more actively in the development and production of new drugs, which increases Avid's order book.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Avid Bioservices Inc.
Avid Bioservices is a contract biopharmaceutical manufacturing organization (CDMO) that manufactures biologics for other companies. Its revenue depends on the number and scale of its contracts. This chart shows analysts' expectations for future revenue, reflecting their views on activity in the biotech industry and demand for outsourced manufacturing services.
Future (predicted) profit of companies in the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Demand for its services is growing as many biotech firms choose to outsource manufacturing. This chart shows profitability projections for the entire sector, allowing you to assess how Avid is benefiting from this long-term trend in the pharmaceutical industry.
Future (predicted) profit of the market as a whole
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Demand for its services depends on the volume of R&D and production plans in the biotech industry. This schedule can have an indirect impact, as the state of the economy affects the ability of pharmaceutical companies to finance their projects.
P/S of the company, segment and market as a whole
P/S - Avid Bioservices Inc.
Avid Bioservices is a contract manufacturer (CDMO) for the pharmaceutical industry. This chart shows how the market perceives its role in the drug development chain. A consistently high value indicates confidence in its manufacturing capacity and long-term contracts with biotech companies, which ensures revenue predictability.
P/S market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Revenue is a payment for manufacturing services. This chart for the pharmaceutical services sector helps assess the premium the market is willing to pay for Avid's manufacturing capacity and expertise, which are critical to bringing drugs to market.
P/S of the market as a whole
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other pharmaceutical companies produce biologics for clinical trials and commercial use. This total market revenue valuation chart helps understand how investors value the outsourcing business, a key component of the pharmaceutical industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps biotech companies produce complex biologics for clinical trials and commercialization. This chart shows how the market values โโfuture revenue from its manufacturing contracts, reflecting the growth of outsourcing in the pharmaceutical industry.
Future (projected) P/S of the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures complex biologics for other pharmaceutical and biotech companies. The company's valuation reflects investors' belief in the growth of outsourcing in the pharmaceutical industry and its ability to attract long-term contracts for the production of promising drugs, ensuring stable revenues.
Future (projected) P/S of the market as a whole
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Its business serves as a barometer of activity in the biotech industry. Revenue growth expectations, as seen here, depend on the drugs Avid currently produces.
Sales of the company, segment and market as a whole
Company sales Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO). This chart shows the company's revenue from providing biologics manufacturing services to other pharmaceutical companies. Growth is driven by new contracts and expanded manufacturing capacity.
Sales of companies in the market segment - Pharma tests
Avid Bioservices (CDMO) is a contract manufacturing organization (CDMO) that helps other pharmaceutical companies develop and manufacture complex biologics. This metric reflects revenue in the pharmaceutical testing and manufacturing sector. Avid Bioservices plays a key role in the industry, enabling innovators to bring their drugs to market faster.
Overall market sales
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Its business depends on the volume of investment in the biotech industry. This general economic activity affects the availability of capital for R&D. Growing markets allow biotech companies to attract financing and place manufacturing orders with Avid.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Avid Bioservices Inc.
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps biotech companies produce protein-based drugs for clinical trials and commercialization. Its revenue is dependent on outsourcing to the pharmaceutical industry. This chart shows analyst revenue expectations, a barometer of the health of the biotech sector.
Future (projected) sales of companies in the market segment - Pharma tests
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other companies produce biopharmaceuticals. This chart segments projected revenue, likely by production stage or client type. This shows how analysts estimate the demand for outsourcing in the biopharmaceutical industry.
Future (projected) sales of the market as a whole
Avid Bioservices is a contract manufacturer of biopharmaceuticals for other companies. Its capacity utilization is an indicator of the health of the entire biotech industry. This chart shows the overall investment climate, while Avid's order book reflects the actual level of activity in clinical trials and commercial production of new drugs.
Marginality of the company, segment and market as a whole
Company marginality Avid Bioservices Inc.
Avid Bioservices is a contract manufacturing organization (CDMO) that helps other pharmaceutical companies produce complex biologics. Profitability depends on the utilization of expensive manufacturing facilities and long-term contracts. The chart shows how successfully Avid converts its pharmaceutical services into profit.
Market segment marginality - Pharma tests
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other pharmaceutical companies produce biologics for clinical trials and commercial use. This chart shows the profitability of its manufacturing business. Success depends on capacity utilization and the quality of its services.
Market marginality as a whole
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. Its business depends on outsourcing volumes within the pharmaceutical industry. This overall profitability chart reflects the performance of its clients. Biotech companies' growing margins allow them to increase their clinical trial and manufacturing budgets, maximizing Avid's capacity.
Employees in the company, segment and market as a whole
Number of employees in the company Avid Bioservices Inc.
Avid Bioservices is a contract manufacturing organization (CDMO) that produces complex biologics for other pharmaceutical companies. This business requires a high level of expertise. This chart shows the size of the company's team of scientists and technicians, which directly impacts the company's production capacity and its ability to serve its customers.
Share of the company's employees Avid Bioservices Inc. within the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures drugs for other companies. It's a service business, where scale is directly related to production capacity and staff qualifications. This chart reflects the company's importance as a key partner for the pharmaceutical industry, measuring its ability to fulfill complex orders.
Number of employees in the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. The employment dynamics in the pharmaceutical research sector, seen here, directly reflect the industry's R&D activity. A growing number of scientists means more new molecules requiring manufacturing capacity, which directly drives Avid's business.
Number of employees in the market as a whole
Avid Bioservices is a contract manufacturing organization (CDMO) that helps other companies manufacture complex biologics. Its business thrives when the biotech industry is booming. The growth in overall employment, reflected in this chart, indicates a healthy economy that attracts investment in R&D and allows biotech startups to bring their developments to the manufacturing stage with Avid's help.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Avid Bioservices Inc. (CDMO)
Avid Bioservices (CDMO) is a contract manufacturer. They help other companies develop and manufacture complex biologics. This business requires significant investment in laboratories and production facilities (capital intensity), but also highly qualified personnel. This metric helps understand the balance: how much the market values โโtheir production assets and expertise per employee.
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biologics for other pharmaceutical companies. Value is created through expertise and state-of-the-art equipment. This metric helps assess how effectively the company utilizes its production capacity and scientific potential to generate market value.
Market capitalization per employee (in thousands of dollars) for the overall market
Avid Bioservices is a contract manufacturing organization (CDMO) that manufactures biopharmaceuticals for other companies. This high-tech production requires sophisticated equipment and skilled specialists. This chart shows how the cost per employee in the biotech service industry reflects the value of expertise and production capacity.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Avid Bioservices Inc. (CDMO)
Avid Bioservices is a contract manufacturing organization (CDMO). They produce complex biologics for other pharmaceutical companies. This B2B service relies on expensive manufacturing facilities and highly qualified personnel for its core assets. This chart demonstrates how effectively Avid manages its capacity utilization, turning research-intensive services into pure profit.
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Avid Bioservices is a contract manufacturer of biologics for other pharmaceutical companies. Efficiency is measured by the ability to optimize complex production processes. This chart shows the profit generated by each employee, reflecting the level of automation, expertise, and operational management at the company.
Profit per employee (in thousands of dollars) for the market as a whole
Avid Bioservices (CDMO) is a contract manufacturing organization (CDMO) for the pharmaceutical industry. They help other companies produce complex biologics (antibodies) for clinical trials and commercialization. This chart measures the average profit per employee across the economy. It provides investors with context: how efficient the biotech manufacturing sector, which requires sophisticated equipment and scientists, is in terms of employee productivity.
Sales to employees of the company, segment and market as a whole
Sales per company employee Avid Bioservices Inc. (CDMO)
Avid Bioservices is a contract development and manufacturing organization (CDMO) that helps other companies produce biopharmaceuticals. Revenue per employee reflects the company's capacity utilization. This chart shows how successfully the company attracts customers and fulfills complex manufacturing orders in the growing biopharmaceutical industry.
Sales per employee in the market segment - Pharma tests
Avid Bioservices (CDMO) is a contract manufacturing organization (CDMO) that helps other biopharmaceutical companies develop and manufacture complex biologics. This chart shows the average revenue per employee in the segment. It helps assess how effectively Avid Bioservices utilizes its highly skilled workforce and manufacturing capacity to generate revenue compared to its competitors.
Sales per employee for the market as a whole
Avid Bioservices (CDMO) is a contract manufacturing organization (CDMO) that helps other biopharmaceutical companies develop and manufacture complex biological drugs (such as antibodies). Their business is high-tech manufacturing. This metric measures the efficiency of their facilities and the productivity of their scientists. It shows how much revenue the company generates per employee.
Short shares by company, segment and market as a whole
Shares shorted by company Avid Bioservices Inc. (CDMO)
Avid Bioservices (CDMO) is a contract manufacturer (CDMO) of complex biologics for other pharmaceutical companies. This business requires significant capital investment and relies on funding from the biotech sector. This chart measures short interest. A rising figure may indicate that investors anticipate a slowdown in orders due to funding issues at clients or fear the loss of a major customer. (349)
Shares shorted by market segment - Pharma tests
Avid Bioservices (CDMO) is a contract manufacturing organization (CDMO) that helps other companies produce complex biologics. Their business is a barometer of R&D activity in biotech. The chart below shows the overall short position for the sector. It shows how many investors are betting on a slowdown in development or a decline in investment in new drugs.
Shares shorted by the overall market
Avid Bioservices is a contract manufacturer (CDMO) for biotech companies. Its clients are R&D companies. This chart illustrates the overall market pessimism. When investors are fearful, they stop funding small biotech companies. As a result, Avid's clients freeze R&D and reduce drug production orders.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Avid Bioservices Inc. (CDMO)
Avid Bioservices (CDMO) is a contract manufacturer (CDMO) that helps other biotech companies produce complex biologics (antibodies) for clinical trials and commercialization. This oscillator measures momentum. It shows when the stock is "overheated" (above 70) on news of capacity occupancy or "oversold" (below 30) on fears of a downturn in biotech.
RSI 14 Market Segment - Pharma tests
Avid Bioservices is a contract development and manufacturing organization (CDMO). They specialize in producing cell culture-based biopharmaceuticals for other pharmaceutical companies. This chart reflects the overall state of the CDMO sector and helps us understand whether the entire segment is overheating amid the rise of biotech outsourcing.
RSI 14 for the overall market
Avid Bioservices (CDMO) is a "service provider" (CRO) for biotechs, producing drugs for them. This chart is an indicator of R&D budgets. In the euphoria of funding, biotechs are generously funded by investors and immediately hire Avid. In a panic, the funding for biotechs is shut off, and contracts for "auxiliary" manufacturing are cut.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CDMO (Avid Bioservices Inc.)
Avid Bioservices is a contract manufacturer (CDMO). They don't have their own drugs, but produce complex biologics (antibody-based) for other biotech companies. This chart shows the average 12-month forecast from analysts. It reflects their view on biotech R&D budgets and capacity utilization.
The difference between the consensus estimate and the actual stock price CDMO (Avid Bioservices Inc.)
Avid Bioservices (CDMO) is a biotech "factory." The company is a pure-play contract manufacturer (CDMO) that helps other pharmaceutical companies produce their complex biologics. This chart shows how far the current share price differs from its "fair" value. It reflects analysts' belief in the demand for outsourcing in the pharmaceutical industry.
Analyst consensus forecast for stock prices by market segment - Pharma tests
Avid Bioservices (CDMO) is a contract manufacturing organization (CDMO). It doesn't develop drugs, but rather produces complex biological drugs (antibodies) for other pharmaceutical companies. This chart shows general expectations for the pharma testing sector (and CDMO). It reflects whether experts believe outsourcing will grow in Big Pharma.
Analysts' consensus forecast for the overall market share price
Avid Bioservices (CDMO) is a "hired drug factory" for biotech. They don't invent drugs, but rather are a contract manufacturer (CDMO) that "brews" complex biologics (antibodies) for other pharmaceutical companies. This chart shows the overall risk appetite. It reflects the level of confidence analysts place in the R&D budgets of "big pharma," Avid's clients.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Avid Bioservices Inc.
Avid is a biotech factory. They're a CDMO (contract manufacturer): they don't have their own drugs; their specialty is producing (in bioreactors) complex biological drugs (antibodies) for other (small) R&D companies. This chart is a barometer of biotech outsourcing. It reflects their backlog and their (high) dependence on the health of the R&D sector.
AKIMA Market Segment Index - Pharma tests
Avid Bioservices (CDMO) is a biotech factory. They don't develop their own drugs, but rather act as a contract manufacturer (CDMO), producing complex biologics for other companies. This chart compares their composite index to the sector, showing how much their manufacturing business outpaces their R&D.
The AKIM Index for the overall market
Avid Bioservices is a contract manufacturing organization (CDMO) specializing in mammalian cell biopharmaceuticals. This chart, which reflects the market average, serves as a backdrop. It helps assess how the CDMO, a biotech manufacturing partner, compares to overall macroeconomic trends and capacity demand.